Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma

Frontiers of Medicine
Weiqi RongTing Xiao

Abstract

Biomarkers for hepatocellular carcinoma (HCC) following curative resection are not currently sufficient for prognostic indication of overall survival (OS) and disease-free survival (DFS). The aim of this study was to investigate the prognostic performance of osteopontin (OPN), matrix metalloproteinase 7 (MMP7), and pregnancy specific glycoprotein 9 (PSG9) in patients with HCC. A total of 179 prospective patients with HCC provided plasma before hepatectomy. Plasma OPN, MMP7, and PSG9 levels were determined by enzyme-linked immunosorbent assay. Correlations between plasma levels, clinical parameters, and outcomes (OS and DFS) were overall analyzed. High OPN ( ⩾ 149.97 ng/mL), MMP7 ( ⩾ 2.28 ng/mL), and PSG9 ( ⩾ 45.59 ng/mL) were prognostic indicators of reduced OS (P < 0.001, P < 0.001, and P = 0.007, respectively). Plasma PSG9 protein level was an independent factor in predicting OS (P = 0.008) and DFS (P = 0.038). Plasma OPN + MMP7 + PSG9 elevation in combination was a prognostic factor for OS (P < 0.001). OPN was demonstrated to be a risk factorassociated OS in stage I patients with HCC and patients with low α-fetoprotein levels ( < 20 ng/mL). These findings suggested that OPN, MMP7, PSG9 and their combined panels may be useful...Continue Reading

References

Jun 19, 2004·Journal of Cancer Research and Clinical Oncology·Lun-Xiu Qin, Zhao-You Tang
Jun 23, 2005·Molecular & Cellular Proteomics : MCP·Ting XiaoShujun Cheng
Jun 21, 2006·Journal of Cancer Research and Clinical Oncology·Hui ZhangLun-Xiu Qin
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ryosuke TateishiMasao Omata
Oct 17, 2008·The New England Journal of Medicine·Morris Sherman
Aug 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tzu-Min HungMing-Fu Chang
Sep 15, 2009·Journal of Hepatology·Jaw-Ching WuWing-Yiu Lui
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Jan 5, 2011·The Journal of Biological Chemistry·Felipe A LisboaGabriela S Dveksler
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Sep 3, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masahiro KobayashiHiromitsu Kumada
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sufen ShangLaura Beretta
Jan 1, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Claire LugassyRaymond L Barnhill
Apr 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beibei LiangJian Zhao
Jan 1, 2014·World Journal of Gastroenterology : WJG·Tao LuMan-Fung Yuen
Jan 8, 2014·Statistical Methods in Medical Research·Jérôme Lambert, Sylvie Chevret
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal

❮ Previous
Next ❯

Citations

Dec 14, 2019·Journal of Experimental & Clinical Cancer Research : CR·Faji YangXiaolei Shi
Nov 18, 2021·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Yingshi ZhangQingchun Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.